Summit Therapeutics

1 trends tracked about this subject — the full history, oldest to newest below.

▲ Peaking Business

Summit Therapeutics and Akeso report that their cancer drug ivonescimab clears the overall survival bar in a Phase 3 trial.

5 sources 5 articles v 3 2h ago

\n \n \n

\n \n \n \n